ANGPT2 and metabolic dysfunction-associated steatohepatitis: Moreover, due to Ang-2 contributing to the progression of NASH, it emerged that Ang-2 inhibitors, such as L1-10, may be effective in the prevention and resolution of steatohepatitis by inhibiting pathological vascular growth and endothelial cell dysfunction.